Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Multidrug-Resistant (MDR-TB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03604848
What this trial is testing

NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 488
Large-scale testing (Phase 3)Study completedNCT02607449
What this trial is testing

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, MDR
Scientific Center for Anti-infectious Drugs, Kazakhstan 344
Not applicableStudy completedNCT07135622
What this trial is testing

Xpert MTB/RIF Ultra Trial

Who this might be right for
Tuberculosis (TB)Pulmonary TB
Nestani Tukvadze 778
Post-approval studies (Phase 4)UnknownNCT04421495
What this trial is testing

Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

Who this might be right for
Multidrug Resistant Tuberculosis
Beijing Chest Hospital 608
Not applicableStudy completedNCT02169141
What this trial is testing

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis
University Medical Center Groningen 20
Large-scale testing (Phase 3)Looking for participantsNCT06441006
What this trial is testing

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco 400
Not applicableUnknownNCT03507816
What this trial is testing

A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Who this might be right for
Tuberculosis
University Hospital, Strasbourg, France 22
Testing effectiveness (Phase 2)Temporarily pausedNCT02354014
What this trial is testing

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Research & Development, LLC 60
Testing effectiveness (Phase 2)Study completedNCT02365623
What this trial is testing

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Pharmaceutical K.K. 6
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Not applicableUnknownNCT04397536
What this trial is testing

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Who this might be right for
Multi-Drug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 172
Not applicableStudy completedNCT00341601
What this trial is testing

Multi-Drug Resistant Tuberculosis in Korea

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 777
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Ended earlyNCT01055145
What this trial is testing

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

Who this might be right for
TB
Seoul National University Hospital 182
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Not applicableStudy completedNCT06671808
What this trial is testing

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

Who this might be right for
HIV InfectionMDR-TB
Zahedan University of Medical Sciences 222,128
Testing effectiveness (Phase 2)Active Not RecruitingNCT03828201
What this trial is testing

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Boston University 271
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Large-scale testing (Phase 3)UnknownNCT05040126
What this trial is testing

Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India

Who this might be right for
Pre-Extensively Drug-Resistant Pulmonary TBTreatment Intolerant Multidrug-Resistant Pulmonary TBNon-responsive Multidrug-Resistant Pulmonary TB
Tuberculosis Research Centre, India 400
Not applicableStudy completedNCT03137875
What this trial is testing

Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis

Who this might be right for
TuberculosisMulti Drug Resistant Tuberculosis
Epicentre 122
Next Page